In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.

Mayne KJ., Herrington WG.

Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. 35023547.

DOI

10.7326/J22-0029

Type

Journal article

Journal

Ann Intern Med

Publication Date

05/2022

Volume

175

Keywords

Diabetes Mellitus, Type 2, Humans, Kidney, Naphthyridines, Renal Insufficiency, Chronic

Permalink Original publication